Themis Medicare Ltd.

Financial

	Themis Medicare	Ind-Swift Lab.	Unichem Lab
Operational Metrics
Pharmaceutical Sector
R&D as a % of Total Sales	2.68 %	3.87 %	0.94 %
Financials
5 yr Average ROE	13.04 %	1.54 %	-1.8 %
5yr average Equity Multiplier	1.72	2.88	1.25
5yr Average Asset Turnover Ratio	0.67	0.52	0.39
5yr Avg Net Profit Margin	11.29 %	0.9 %	-3.43 %
Price to Book	5.5	1.0	1.71
P/E	44.26	16.47	282.72
5yr Avg Cash Conversion Cycle	62.75 Days	169.25 Days	134.58 Days
Inventory Days	82.4 Days	144.46 Days	136.89 Days
Days Receivable	126.49 Days	144.51 Days	147.31 Days
Days Payable	162.52 Days	91.2 Days	232.31 Days
5yr Average Interest Coverage Ratio	5.22	1.32	-1.13
5yr Avg ROCE	16.01 %	8.03 %	-1.02 %
5yr Avg Operating Profit Margin	18.66 %	22.42 %	5.06 %
5 yr average Debt to Equity	0.4	1.6	0.09
5yr CAGR Net Profit	n/a	10.46 %	53.41 %
5yr Average Return on Assets	8.13 %	0.55 %	-1.39 %
Shareholdings
Promoter Holding	67.15 %	42.0 %	70.22 %
Share Pledged by Promoters	2.43 %	48.57 %	0.0
Change in Promoter Holding (3 Yrs)	-0.11 %	0.0	19.29 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	1.59 %

Business

	Themis Medicare	Ind-Swift Lab.	Unichem Lab
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Formulation 0 API 0 Bulk Drugs and chemicals 0 Formulations 0	Product Wise Break-Up Pharmaceutical 0 Formulations 0 API 0 Formulation 0 Bulk Drugs and chemicals 0 Others 100	Product Wise Break-Up Pharmaceutical 0 Formulations 88.93 API 0 Formulation 0 Bulk Chemicals 11.07
Location Wise Break-Up	Location Wise Break-Up India 58.97 Rest of the World 41.03 North America 0 Africa 0 Latin America 0 SE Asia 0 Europe 0 USA 0	Location Wise Break-Up North America 0 India 22.36 Latin America 0 Europe 0 SE Asia 0 USA 0 Africa 0 Rest of the World 0 Others 77.64	Location Wise Break-Up North America 0 India 2.47 Latin America 0 Europe 0 SE Asia 0 USA 60.32 Africa 0 Rest of the World 0 Others 37.21
Verticals	Verticals API & Co. Mkt 45.0 Hospital 38.0 Trade 17.0	-	-